State Street’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,271
Closed -$12.9K 4517
2023
Q3
$12.9K Hold
2,271
﹤0.01% 4487
2023
Q2
$17.7K Hold
2,271
﹤0.01% 4601
2023
Q1
$26.5K Hold
2,271
﹤0.01% 4643
2022
Q4
$26.7K Hold
2,271
﹤0.01% 4685
2022
Q3
$51K Hold
2,271
﹤0.01% 4651
2022
Q2
$67K Buy
2,271
+112
+5% +$3.34K ﹤0.01% 4660
2022
Q1
$72K Hold
2,159
﹤0.01% 4725
2021
Q4
$87K Buy
2,159
+850
+65% +$50.3K ﹤0.01% 4608
2021
Q3
$106K Buy
+1,309
New +$117K ﹤0.01% 4533

Other funds holding NURO

State Street's NURO Position: Q4 2023 in Review

State Street sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2023, closing a stake of 2,271 shares — an estimated $12.9K sold.

State Street first reported a position in NURO in Q3 2021 and held it in 9 quarters. The position peaked at $106K in Q3 2021. 13 funds tracked by Wall St. Rank hold NURO as of Q4 2023.

  • State Street reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • State Street sold 2,271 NeuroMetrix, Inc. Common Stock shares in Q4 2023, an estimated $12.9K.
  • State Street first reported a position in NeuroMetrix, Inc. Common Stock in Q3 2021 and held it in 9 quarters.
  • State Street's NeuroMetrix, Inc. Common Stock position peaked at $106K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.